Current Investors




BIOCANT Park is the first Portuguese venue entirely devoted to Biotechnology. Here, advanced Life Sciences knowledge and technology are developed and applied creating value in business initiatives. Through an audacious investment by the Municipality of Cantanhede and by the Center for Neuroscience and Cell Biology of Coimbra, and taking advantage of the last years’ national investment in Life Sciences, it was possible to set out an integrated development strategy to promote entrepreneurship and economic growth. The core of the Park is the R&D center – BIOCANT, Biotechnology Innovation Center – where specialized research teams use their built-up scientific competences to generate novel services and products. The scientific units of BIOCANT have committed staff and state-of-the-art equipment with high-throughput capacity.


Biocant Park and Beta SCR, a private venture capital company, founded Biocant Ventures in 2006. Biocant Ventures is the first Portuguese company whose main objective is to invest in biotech projects available to big investors. The company tests and validates concepts and business ideas of early-stage biotechnology projects, as some of them can not be legally supported by Venture Capitalists because are not yet formalized as companies. Biocant Ventures is the first business angel company investing exclusively in Life Sciences projects. The company aims at generating economic value through technology licensing.

Additional funding


Matera has also secured funding from QREN. The National Strategic Reference Framework (NSRF) constitutes the framing for the application of the Community’s policy for economic and social cohesion in Portugal for the 2007-2013 period.